Member Info for DaddyAIM

yep - agreed - strong buy at this level

up

using a 25x fwd EPS multiple. c. 30% more downside. see you there.

can't understand the weakness in the share price since the last update.
strong and positive growth: revenue, EBITDA, NI, EPS, OCF
margin expansion: Gross margin and net income

not sure what's hard to understand?

i won't deny your last sentence.

there is a thin line between being balanced and realist in a market where growth/expensive stocks are being punished. See what can a style rotation do to a "good business": -38% ytd.
After listening the preso, I will reiterate my view: down until the next trading update c. mid September.
SEE YOU LOWER.

needed to fuel growth. they've been delivering. CYAN is far from being mature, don't expect quality in the numbers... BUY

• a very lukewarm update for such an expansive stock
• a gloomy outlook "We do expect the advertising market to be further tested by the economic downturn and we are seeing a softening in advertiser demand for Q3 2022 as lower consumer spending impacts the confidence of brands in the space."
• overly greedy management: $2.3m of share based payment
• view: going down until the next trading update in mid September

fwd P/E 56x still too high.

up

people that can't bother reading the RNS should be allowed to comment...

strong buy

strong BUY:
- business is delivering
- structural tailwind drivers as highlighted by the recent jumbo contract
- positive outlook

yoy gowth: strong across the board

Revenue: 78.9%
EBITDA: 138.4%
NI: 98.2%
EPS: 99.4%
OCF: -137.5%

clearly cash generation is the only negative.
looking at note 28. Cash used in operations, the main detractors were:
- Exceptional items => - Transaction (gain) relating to Capital Reduction and spin out (note 39) => one off
- Change in working capital mix: the decrease in trade payables which should prove a short term issue and is part of the way a business passes.
- R&D: doubled, would be nice to clarify with management a certain guidance on future R&D spend

=> all in all, 2/3 detractors to cash generation are transitory.

yoy margin change:

EBITDA: 48%
NIM: 50%
OCF margin: -24%
Cash Conversion: + 1%

Outlook: positive

"As at 1 June 2022, Open Orphan had an order book of signed contracts worth £64.2m which is expected to be recognised across 2022, 2023 and 2024. These developments reaffirm the Board's expectations of a profitable growing business with revenues in the region of £50m in 2022.The Group is now well positioned and well capitalised to deliver sustainable long-term profitability."

expensive.

Yep - and these multiples are freaking high!

gallder, yes EPS are in cents because the price is in cents too.

Price = 1,262.5
FY22 EPS = 20.7 so P/E = 61x
FY23 EPS = 33 so P/E = 38x

in a rising rate / inflationary environment such multiples are discounting a lot of growth. Period.

Valuations remain sky high. The stock already discounts a hell of a lot of growth. Base case, the stock flat line as valuation multiples compress (lead by stronger EPS growth). Worst case, stock derate fast and multiples mean revert, mostly led by a falling share price. Best case: TAke over at a premium.

Lmao

What are your P/E ? Lmao